Cargando…
Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient
We report a dystrophinopathy patient with an in-frame deletion of DMD exons 45–47, and therefore a genetic diagnosis of Becker muscular dystrophy, who presented with a more severe than expected phenotype. Analysis of the patient DMD mRNA revealed an 82 bp pseudoexon, derived from intron 44, that dis...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521967/ https://www.ncbi.nlm.nih.gov/pubmed/26247048 http://dx.doi.org/10.1002/mgg3.144 |
_version_ | 1782383894547398656 |
---|---|
author | Greer, Kane Mizzi, Kayla Rice, Emily Kuster, Lukas Barrero, Roberto A Bellgard, Matthew I Lynch, Bryan J Foley, Aileen Reghan O Rathallaigh, Eoin Wilton, Steve D Fletcher, Sue |
author_facet | Greer, Kane Mizzi, Kayla Rice, Emily Kuster, Lukas Barrero, Roberto A Bellgard, Matthew I Lynch, Bryan J Foley, Aileen Reghan O Rathallaigh, Eoin Wilton, Steve D Fletcher, Sue |
author_sort | Greer, Kane |
collection | PubMed |
description | We report a dystrophinopathy patient with an in-frame deletion of DMD exons 45–47, and therefore a genetic diagnosis of Becker muscular dystrophy, who presented with a more severe than expected phenotype. Analysis of the patient DMD mRNA revealed an 82 bp pseudoexon, derived from intron 44, that disrupts the reading frame and is expected to yield a nonfunctional dystrophin. Since the sequence of the pseudoexon and canonical splice sites does not differ from the reference sequence, we concluded that the genomic rearrangement promoted recognition of the pseudoexon, causing a severe dystrophic phenotype. We characterized the deletion breakpoints and identified motifs that might influence selection of the pseudoexon. We concluded that the donor splice site was strengthened by juxtaposition of intron 47, and loss of intron 44 silencer elements, normally located downstream of the pseudoexon donor splice site, further enhanced pseudoexon selection and inclusion in the DMD transcript in this patient. |
format | Online Article Text |
id | pubmed-4521967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-45219672015-08-05 Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient Greer, Kane Mizzi, Kayla Rice, Emily Kuster, Lukas Barrero, Roberto A Bellgard, Matthew I Lynch, Bryan J Foley, Aileen Reghan O Rathallaigh, Eoin Wilton, Steve D Fletcher, Sue Mol Genet Genomic Med Original Articles We report a dystrophinopathy patient with an in-frame deletion of DMD exons 45–47, and therefore a genetic diagnosis of Becker muscular dystrophy, who presented with a more severe than expected phenotype. Analysis of the patient DMD mRNA revealed an 82 bp pseudoexon, derived from intron 44, that disrupts the reading frame and is expected to yield a nonfunctional dystrophin. Since the sequence of the pseudoexon and canonical splice sites does not differ from the reference sequence, we concluded that the genomic rearrangement promoted recognition of the pseudoexon, causing a severe dystrophic phenotype. We characterized the deletion breakpoints and identified motifs that might influence selection of the pseudoexon. We concluded that the donor splice site was strengthened by juxtaposition of intron 47, and loss of intron 44 silencer elements, normally located downstream of the pseudoexon donor splice site, further enhanced pseudoexon selection and inclusion in the DMD transcript in this patient. John Wiley & Sons, Ltd 2015-07 2015-04-15 /pmc/articles/PMC4521967/ /pubmed/26247048 http://dx.doi.org/10.1002/mgg3.144 Text en © 2015 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Greer, Kane Mizzi, Kayla Rice, Emily Kuster, Lukas Barrero, Roberto A Bellgard, Matthew I Lynch, Bryan J Foley, Aileen Reghan O Rathallaigh, Eoin Wilton, Steve D Fletcher, Sue Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient |
title | Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient |
title_full | Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient |
title_fullStr | Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient |
title_full_unstemmed | Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient |
title_short | Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient |
title_sort | pseudoexon activation increases phenotype severity in a becker muscular dystrophy patient |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521967/ https://www.ncbi.nlm.nih.gov/pubmed/26247048 http://dx.doi.org/10.1002/mgg3.144 |
work_keys_str_mv | AT greerkane pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient AT mizzikayla pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient AT riceemily pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient AT kusterlukas pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient AT barrerorobertoa pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient AT bellgardmatthewi pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient AT lynchbryanj pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient AT foleyaileenreghan pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient AT orathallaigheoin pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient AT wiltonsteved pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient AT fletchersue pseudoexonactivationincreasesphenotypeseverityinabeckermusculardystrophypatient |